PAPER Picone P, Nuzzo D, Giacomazza D, Di Carlo M
SEARCH RESULTS
4076 RESULTS
PAPER Leong YQ, Ng KY, Chye SM, Ling AP, Koh RY
Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death.
Metab Brain Dis. 2020 Jan;35(1):11-30. Epub 2019 Dec 6 PubMed: 31811496PAPER Sala A, Caprioglio C, Santangelo R, Vanoli EG, Iannaccone S, Magnani G, Perani D
Brain metabolic signatures across the Alzheimer's disease spectrum.
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):256-269. Epub 2019 Dec 7 PubMed: 31811345PAPER Son HJ, Oh JS, Oh M, Kim SJ, Lee JH, Roh JH, Kim JS
The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases.
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):332-341. Epub 2019 Dec 6 PubMed: 31811343PAPER Dharshini SA, Taguchi YH, Gromiha MM
Investigating the energy crisis in Alzheimer disease using transcriptome study.
Sci Rep. 2019 Dec 6;9(1):18509. PubMed: 31811163PAPER Zhao X, Kang J, Svetnik V, Warden D, Wilcock G, David Smith A, Savage MJ, Laterza OF
A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease.
J Appl Lab Med. 2020 Jan 1;5(1):15-28. PubMed: 31811079PAPER Mielke MM
Consideration of Sex Differences in the Measurement and Interpretation of Alzheimer Disease-Related Biofluid-Based Biomarkers.
J Appl Lab Med. 2020 Jan 1;5(1):158-169. PubMed: 31811073PAPER Joe E, Ringman JM
Cognitive symptoms of Alzheimer's disease: clinical management and prevention.
BMJ. 2019 Dec 6;367:l6217. PubMed: 31810978PAPER van Veluw SJ, Hou SS, Calvo-Rodriguez M, Arbel-Ornath M, Snyder AC, Frosch MP, Greenberg SM, Bacskai BJ
Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain.
Neuron. 2020 Feb 5;105(3):549-561.e5. Epub 2019 Dec 3 PubMed: 31810839PAPER Moore KM, Nicholas J, Grossman M, McMillan CT, Irwin DJ, Massimo L, Van Deerlin VM, Warren JD, Fox NC, Rossor MN, Mead S, Bocchetta M, Boeve BF, Knopman DS, Graff-Radford NR, Forsberg LK, Rademakers R, Wszolek ZK, van Swieten JC, Jiskoot LC, Meeter LH, Dopper EG, Papma JM, Snowden JS, Saxon J, Jones M, Pickering-Brown S, Le Ber I, Camuzat A, Brice A, Caroppo P, Ghidoni R, Pievani M, Benussi L, Binetti G, Dickerson BC, Lucente D, Krivensky S, Graff C, Öijerstedt L, Fallström M, Thonberg H, Ghoshal N, Morris JC, Borroni B, Benussi A, Padovani A, Galimberti D, Scarpini E, Fumagalli GG, Mackenzie IR, Hsiung GR, Sengdy P, Boxer AL, Rosen H, Taylor JB, Synofzik M, Wilke C, Sulzer P, Hodges JR, Halliday G, Kwok J, Sanchez-Valle R, Lladó A, Borrego-Ecija S, Santana I, Almeida MR, Tábuas-Pereira M, Moreno F, Barandiaran M, Indakoetxea B, Levin J, Danek A, Rowe JB, Cope TE, Otto M, Anderl-Straub S, de Mendonça A, Maruta C, Masellis M, Black SE, Couratier P, Lautrette G, Huey ED, Sorbi S, Nacmias B, Laforce R Jr, Tremblay ML, Vandenberghe R, Damme PV, Rogalski EJ, Weintraub S, Gerhard A, Onyike CU, Ducharme S, Papageorgiou SG, Ng AS, Brodtmann A, Finger E, Guerreiro R, Bras J, Rohrer JD, FTD Prevention Initiative
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.
Lancet Neurol. 2020 Feb;19(2):145-156. Epub 2019 Dec 3 PubMed: 31810826PAPER Vu M, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Kettunen R, Hartikainen S, Tolppanen AM
Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease.
Int J Cardiol. 2020 Feb 1;300:221-225. Epub 2019 Oct 30 PubMed: 31810814PAPER Rosas I, Martínez C, Clarimón J, Lleó A, Illán-Gala I, Dols-Icardo O, Borroni B, Almeida MR, van der Zee J, Van Broeckhoven C, Bruni AC, Anfossi M, Bernardi L, Maletta R, Serpente M, Galimberti D, Scarpini E, Rossi G, Caroppo P, Benussi L, Ghidoni R, Binetti G, Nacmias B, Sorbi S, Piaceri I, Bagnoli S, Antonell A, Sánchez-Valle R, De la Casa-Fages B, Grandas F, Diez-Fairen M, Pastor P, Ferrari R, Álvarez V, Menéndez-González M
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease.
Neurobiol Aging. 2020 Mar;87:139.e1-139.e7. Epub 2019 Nov 1 PubMed: 31810584PAPER Reimand J, de Wilde A, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, Barkhof F, van der Flier WM, Scheltens P, van Berckel BN, Ossenkoppele R, Bouwman F
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases.
Alzheimers Res Ther. 2019 Dec 7;11(1):100. PubMed: 31810489PAPER Chen Y, Chen Y, Liang Y, Chen H, Ji X, Huang M
Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
Biomed Pharmacother. 2020 Jan;121:109670. Epub 2019 Nov 22 PubMed: 31810131PAPER Zhang S, Zhang J, Wei D, An H, Liu W, Lai Y, Yang T, Shao W, Huang Y, Wang L, Dou F, Peng D, Zhang Z
Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation.
Biomed Pharmacother. 2020 Jan;121:109682. Epub 2019 Nov 25 PubMed: 31810113Current Filters
- Date Range : Sep 2019 to Dec 2019 x